• DLH Holdings posted fiscal 2026 second-quarter net loss of $2.5 million, swinging from profit, as revenue fell 33.5% to $59.3 million.
• Adjusted EBITDA dropped 43.6% to $5.3 million, while adjusted EBITDA margin narrowed 1.5 percentage points to 9%.
• Free cash flow declined 73.8% to $3.8 million; debt fell to $132.7 million from $136.6 million at end of fiscal first quarter.
• Backlog slid 14% to $442.4 million; DLH also won a two-year sole-source extension to provide clinical research support services to NIH.
• CEO Zach Parker said fiscal 2026 is a transition year as legacy contracts convert to small-business set-asides, expected to be completed in third quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DLH Holdings Corp. published the original content used to generate this news brief on May 06, 2026, and is solely responsible for the information contained therein.